Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Ann Yancey

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Journal of Oncology Nursing|October 10, 2008
Oncology drug development: what is changing?Mary Ann Yancey
Clinical Journal of Oncology Nursing|April 8, 2009
Sezary syndrome: a case study of cutaneous T-cell lymphomaSonja Crandon, Mary Ann Yancey
Clinical Journal of Oncology Nursing|August 5, 2010
A case study progression to multiple myelomaMary Ann Yancey, Adam J Waxman, Ola Landgren
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 29, 2012
A phase I combination study of olaparib with cisplatin and gemcitabine in adults with solid tumorsArun Rajan, Corey A Carter, Ronan J Kelly, et al.
Leukemia & Lymphoma|January 15, 2013
Modeling progression risk for smoldering multiple myeloma: results from a prospective clinical studyBenjamin M Cherry, Neha Korde, Mary Kwok, et al.
Cytokine|July 22, 2014
Altered cytokine and chemokine profiles in multiple myeloma and its precursor diseaseAdriana Zingone, Weixin Wang, Meghan Corrigan-Cummins, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 2009
Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignanciesShivaani Kummar, Martin E Gutierrez, Erin R Gardner, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Journal of Oncology Nursing|October 10, 2008
Oncology drug development: what is changing?Mary Ann Yancey
Clinical Journal of Oncology Nursing|April 8, 2009
Sezary syndrome: a case study of cutaneous T-cell lymphomaSonja Crandon, Mary Ann Yancey
Clinical Journal of Oncology Nursing|August 5, 2010
A case study progression to multiple myelomaMary Ann Yancey, Adam J Waxman, Ola Landgren
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 29, 2012
A phase I combination study of olaparib with cisplatin and gemcitabine in adults with solid tumorsArun Rajan, Corey A Carter, Ronan J Kelly, et al.
Leukemia & Lymphoma|January 15, 2013
Modeling progression risk for smoldering multiple myeloma: results from a prospective clinical studyBenjamin M Cherry, Neha Korde, Mary Kwok, et al.
Cytokine|July 22, 2014
Altered cytokine and chemokine profiles in multiple myeloma and its precursor diseaseAdriana Zingone, Weixin Wang, Meghan Corrigan-Cummins, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 2009
Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignanciesShivaani Kummar, Martin E Gutierrez, Erin R Gardner, et al.
Pageof 1